SRTA Insider Trading Activity and SEC Form 4 Filings
SRTA insider trading summary
Over the past 12 months, insiders at Strata Critical Medical, Inc. (SRTA) reported 10 sales worth $927K by 5 insiders and 2 open-market purchases worth $98K by 2 insiders on SEC Form 4. Net insider selling was $830K.
Latest SRTA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 10, 2026 | Reginald Love | Director | Sell | $29K (5,091 @ $5.75) |
| Jun 8, 2026 | Melissa M. Tomkiel | Co-CEO and General Counsel | Sell | $175K (29,730 @ $5.87) |
| Jun 8, 2026 | Amir Cohen | Chief Accounting Officer | Sell | $27K (4,655 @ $5.87) |
| Jun 8, 2026 | William A. Heyburn | Co-CEO and CFO | Sell | $186K (31,671 @ $5.87) |
| Jun 8, 2026 | Scott M Wunsch | CEO, Logistics | Sell | $33K (5,550 @ $5.87) |
| May 22, 2026 | Amir Cohen | Chief Accounting Officer | Sell | $240K (40,575 @ $5.91) |
| May 21, 2026 | Amir Cohen | Chief Accounting Officer | Sell | $60K (10,300 @ $5.79) |
| May 11, 2026 | Amir Cohen | Chief Accounting Officer | Sell | $83K (14,306 @ $5.79) |
| Dec 9, 2025 | William A. Heyburn | Co-CEO and CFO | Buy | $76K (17,000 @ $4.47) |
| Dec 5, 2025 | Andrew Lauck | Director | Buy | $22K (5,000 @ $4.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.